NO20015722L - Antibakterielle forbindelser - Google Patents

Antibakterielle forbindelser

Info

Publication number
NO20015722L
NO20015722L NO20015722A NO20015722A NO20015722L NO 20015722 L NO20015722 L NO 20015722L NO 20015722 A NO20015722 A NO 20015722A NO 20015722 A NO20015722 A NO 20015722A NO 20015722 L NO20015722 L NO 20015722L
Authority
NO
Norway
Prior art keywords
antibacterial compounds
antibacterial
compounds
Prior art date
Application number
NO20015722A
Other languages
English (en)
Other versions
NO20015722D0 (no
Inventor
William H Miller
Kenneth Allen Newlander
Mark Seefeld
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20015722D0 publication Critical patent/NO20015722D0/no
Publication of NO20015722L publication Critical patent/NO20015722L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20015722A 1999-06-01 2001-11-23 Antibakterielle forbindelser NO20015722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13700499P 1999-06-01 1999-06-01
PCT/US2000/015154 WO2000072846A1 (en) 1999-06-01 2000-06-01 Antibacterial compounds

Publications (2)

Publication Number Publication Date
NO20015722D0 NO20015722D0 (no) 2001-11-23
NO20015722L true NO20015722L (no) 2001-11-23

Family

ID=22475391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015722A NO20015722L (no) 1999-06-01 2001-11-23 Antibakterielle forbindelser

Country Status (23)

Country Link
US (2) US6573272B1 (no)
EP (1) EP1180030B1 (no)
JP (1) JP4733836B2 (no)
KR (1) KR20020005767A (no)
CN (1) CN1365280A (no)
AR (1) AR024158A1 (no)
AT (1) ATE283049T1 (no)
AU (1) AU773550B2 (no)
BR (1) BR0011121A (no)
CA (1) CA2375630A1 (no)
CO (1) CO5370679A1 (no)
CZ (1) CZ20014290A3 (no)
DE (1) DE60016198T2 (no)
HK (1) HK1045644A1 (no)
HU (1) HUP0201206A3 (no)
IL (1) IL146514A0 (no)
MX (1) MXPA01012326A (no)
NO (1) NO20015722L (no)
NZ (1) NZ515611A (no)
PL (1) PL351959A1 (no)
TR (1) TR200103485T2 (no)
WO (1) WO2000072846A1 (no)
ZA (1) ZA200109733B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
CO5251397A1 (es) * 1999-10-08 2003-02-28 Smithkline Beecham Corp Inhibidores de fab i
ATE285821T1 (de) * 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
EP1347759B1 (en) * 2000-12-08 2005-06-29 Smithkline Beecham Corporation Antibacterial compounds
AU2002237731B2 (en) * 2000-12-21 2007-03-22 Michael J. Kirisits Fab I and inhibition of apicomplexan parasites
JP4220779B2 (ja) * 2001-02-12 2009-02-04 リリー アイコス リミテッド ライアビリティ カンパニー 化学化合物
CA2444597A1 (en) * 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1575951B1 (en) * 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
DE602004016831D1 (de) * 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
WO2004096802A2 (en) * 2003-04-29 2004-11-11 Oscient Pharmaceuticals ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES
EP2848614A3 (en) * 2004-06-04 2015-07-29 Debiopharm International SA Acrylamide derivatives as antibiotic agents
EP1973902A2 (en) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2687533B1 (en) * 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
US7854963B2 (en) * 2006-10-13 2010-12-21 Solopower, Inc. Method and apparatus for controlling composition profile of copper indium gallium chalcogenide layers
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
EP2225250A2 (en) * 2007-11-30 2010-09-08 Biota Scientific Management Pty Ltd Bicyclic ppat inhibitors as antibacterial agents
KR101135179B1 (ko) * 2009-02-20 2012-04-16 한국생명공학연구원 ＦａｂＩ 저해 물질 비나산손을 포함하는 항균용 조성물
ES2587856T3 (es) 2011-03-18 2016-10-27 Ono Pharmaceutical Co., Ltd. Derivado de tetrahidrocarbolina
SI2861608T1 (sl) 2012-06-19 2019-08-30 Debiopharm International Sa Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
CN112654354A (zh) * 2018-08-16 2021-04-13 菲尼克思药业股份有限公司 1,3,4,9-四氢-2H-吡啶并[3,4-b]吲哚衍生物化合物及其用途
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828068A (en) 1971-05-10 1974-08-06 Tenneco Chem ((substituted indazolyl)-n1-methyl)carbamates
US4154943A (en) * 1977-12-29 1979-05-15 University Of Vermont Preparation of vincadifformine
US4267330A (en) * 1978-08-24 1981-05-12 Omnium Chimique Societe Anonyme Process for the synthesis of vincadifformine and related derivatives
FR2619111B1 (fr) 1987-08-07 1991-01-11 Synthelabo Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5416193A (en) * 1993-04-30 1995-05-16 Pfizer Inc. Coupling reagent and method
MA23420A1 (fr) 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US5614551A (en) 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
EP0767792A4 (en) 1994-06-29 2002-11-20 Smithkline Beecham Corp VITRONECTIN RECEPTOR ANTAGONISTS
US6451816B1 (en) 1997-06-20 2002-09-17 Klinge Pharma Gmbh Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
DE19624659A1 (de) 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalken- und Pyridylalkinsäureamide
JPH10310582A (ja) * 1997-03-13 1998-11-24 Sankyo Co Ltd ピペリジン環縮合カルバペネム化合物
EP0973767A1 (en) 1997-03-31 2000-01-26 Dupont Pharmaceuticals Company Indazoles of cyclic ureas useful as hiv protease inhibitors
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US5932743A (en) 1997-08-21 1999-08-03 American Home Products Corporation Methods for the solid phase synthesis of substituted indole compounds
HU227568B1 (en) * 1997-12-24 2011-08-29 Sanofi Aventis Deutschland Indole derivatives, as inhibitors os factor xa
ATE291423T1 (de) * 1998-08-20 2005-04-15 Agouron Pharma Nicht-peptidische gnrh agentia, verfahren und zwischenverbindungen zur ihren herstellung
GT199900167A (es) * 1998-10-01 2001-03-21 Nuevos bis-benzimidazoles.
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
AR024077A1 (es) 1999-05-25 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
CO5180605A1 (es) 1999-06-23 2002-07-30 Smithkline Beecham Corp Compuestos de indol
US6346391B1 (en) 1999-07-22 2002-02-12 Trustees Of Tufts College Methods of reducing microbial resistance to drugs
ATE294578T1 (de) 1999-10-08 2005-05-15 Affinium Pharm Inc Fab i hemmer
ATE285821T1 (de) 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
CO5251397A1 (es) 1999-10-08 2003-02-28 Smithkline Beecham Corp Inhibidores de fab i
US6503908B1 (en) 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds
US6656703B1 (en) 1999-12-29 2003-12-02 Millennium Pharamaceuticals, Inc. High throughput screen for inhibitors of fatty acid biosynthesis in bacteria
US6372752B1 (en) 2000-02-07 2002-04-16 Genzyme Corporation Inha inhibitors and methods of use thereof
US6642252B2 (en) 2000-11-07 2003-11-04 Bristol-Myers Squibb Company Acid derivatives useful as serine protease inhibitors
AU2002232558A1 (en) 2000-12-12 2002-06-24 Corvas International, Inc. Compounds, compositions and methods for treatment of parasitic infections

Also Published As

Publication number Publication date
NZ515611A (en) 2004-05-28
AU5177400A (en) 2000-12-18
TR200103485T2 (tr) 2002-04-22
JP2003500448A (ja) 2003-01-07
AU773550B2 (en) 2004-05-27
NO20015722D0 (no) 2001-11-23
ATE283049T1 (de) 2004-12-15
BR0011121A (pt) 2002-02-26
PL351959A1 (en) 2003-07-14
WO2000072846A1 (en) 2000-12-07
KR20020005767A (ko) 2002-01-17
US6573272B1 (en) 2003-06-03
DE60016198T2 (de) 2005-12-01
CA2375630A1 (en) 2000-12-07
EP1180030A4 (en) 2002-09-25
JP4733836B2 (ja) 2011-07-27
MXPA01012326A (es) 2002-07-30
HK1045644A1 (zh) 2002-12-06
IL146514A0 (en) 2002-07-25
US20030232850A1 (en) 2003-12-18
AR024158A1 (es) 2002-09-04
US6964970B2 (en) 2005-11-15
EP1180030B1 (en) 2004-11-24
CN1365280A (zh) 2002-08-21
ZA200109733B (en) 2002-09-11
CZ20014290A3 (cs) 2002-05-15
DE60016198D1 (de) 2004-12-30
EP1180030A1 (en) 2002-02-20
HUP0201206A2 (en) 2002-08-28
HUP0201206A3 (en) 2003-07-28
CO5370679A1 (es) 2004-02-27

Similar Documents

Publication Publication Date Title
EE200100502A (et) Ühendid
ATE344248T1 (de) Antibakterielle verbindungen
NO20015722L (no) Antibakterielle forbindelser
EE200200033A (et) Uued ühendid
PT1206469E (pt) Fenil-oxazolidinonas substituidas heterociclicas antibacterianas
EE200200224A (et) Uudsed ühendid
DE60006227D1 (de) Antimikrobielle gegenstände
IS6139A (is) Ný efnasambönd
NO20020621D0 (no) Antibakterielle midler
DE60102936D1 (de) Antibakterielle mutiline
ID29533A (id) Senyawa-senyawa kalsilitik
NO20020466D0 (no) Kalsilytiske forbindelser
IS6141A (is) Ný efnasambönd
NO20014262D0 (no) Tiazoloindolinon-forbindelser
ID29984A (id) Senyawa-senyawa bis-stirilbifenil
ATE251154T1 (de) Substituierte phenyluracile
SE9902903D0 (sv) Novel compounds
SE9902764D0 (sv) Novel compounds
SE9904651D0 (sv) Novel compounds
SE9902194D0 (sv) Novel compounds
SE9901078D0 (sv) Novel compounds
SE9901117D0 (sv) Novel compounds
SE9903838D0 (sv) Novel compounds
SE9901118D0 (sv) Novel compounds
SE9901270D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application